Health
AHA: New Medication, Finerenone, Helps Heart Health in People With Chronic Kidney Disease, Type 2 Diabetes – Cath Lab Digest
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events…
DALLAS, Nov. 17, 2020 — The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events in patients with chronic kidney disease and Type 2 diabetes, according to late-breaking research presented at the American Heart Association’s Scientific Sessions 2020. The virtual meeting is Friday, November 13-Tuesday, November 17, 2020, and is a premier global exchange of the latest scientific advancements, research and evidence-based…
-
Noosa News17 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
Noosa News24 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General17 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News8 hours agoNew playground equipment encourages children to learn through ‘risky play’